PMC:7200337 / 70806-70981
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T640 | 155-158 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
| T641 | 163-166 | Body_part | denotes | DNA | http://purl.org/sig/ont/fma/fma74412 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T421 | 64-72 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T422 | 124-132 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T809 | 49-55 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
| T810 | 167-174 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T45425 | 33-48 | Chemical | denotes | antiviral drugs | http://purl.obolibrary.org/obo/CHEBI_36044 |
| T117 | 33-42 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T82551 | 43-48 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T119 | 85-94 | Chemical | denotes | molecules | http://purl.obolibrary.org/obo/CHEBI_25367 |
| T10628 | 163-166 | Chemical | denotes | DNA | http://purl.obolibrary.org/obo/CHEBI_16991 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2225 | 64-74 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 2226 | 124-132 | Species | denotes | SARS-CoV | Tax:694009 |
| 2227 | 136-144 | Species | denotes | MERS-CoV | Tax:1335626 |
| 2228 | 163-174 | Species | denotes | DNA viruses | Tax:2080735 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T395 | 0-175 | Sentence | denotes | Currently, most of the available antiviral drugs tested against SARS-CoV-2 are small molecules previously developed against SARS-CoV-1, MERS-CoV, or other RNA and DNA viruses. |